This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

USPLabs Throws in the Towel on DMAA

DALLAS—USPLabs appears to have withdrawn from its fight with FDA over the safety and legality of DMAA (1,3 dimethylamylamine ) as a dietary supplement, according to a press release April 16 announcing the planned reformulation to remove DMAA from the company's products.

In its release, USPLabs said it still believes DMAA is both legal and safe as a dietary supplement, but the company plans to phase-out products containing DMAA and replace them with new formulations for business reasons. "Despite being among the most studied ingredients ever with 11 published peer-reviewed clinical and analytical studies, the FDA has urged the industry to discontinue the use of 1,3-DMAA in dietary supplements," the company said, in the press release, emphasizing it disagrees with FDA's position.

The webpage for USPLabs Jackd 3D product, one of the DMAA-containing hold outs, now bears a big "Coming Soon" image across the product's image and tells visitors to "Look for new advanced formulas coming soon!"

FDA issued a public warning on April 12, calling DMAA a dangerous stimulant and advising consumers to avoid consuming any products containing the ingredient. The agency effectively said it rejected research supplied by USPLabs and would do everything it could to remove the ingredient from the dietary supplement market.

comments powered by Disqus